White label ELPA - ClinicalTrials.eu

Study on the Safety and Effectiveness of Trastuzumab Deruxtecan and Drug Combination for Patients with HER2-Positive Gastric, GEJ, and Esophageal Cancer

Recruiting

1 1 1 1
Investigated drugs:
Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Recruiting

3 1 1 1
Investigated diseases:
- Hormone-refractory prostate cancer
Investigated drugs:
+6
Study on the Effectiveness and Safety of Human Normal Immunoglobulin (IV) for Adults with Chronic Immune Thrombocytopenia

Recruiting

3 1 1
Investigated diseases:
- Thrombocytopenia
Investigated drugs:
- Human Normal Immunoglobulin (Iv)
Study on Botulinum Toxin A for Tinnitus in Patients with Bruxism or Jaw Muscle Pain

Recruiting

3 1 1
Investigated diseases:
- Tinnitus
Investigated drugs:
- Botulinum Toxin Type A
- Sodium Chloride
Long-Term Study on the Safety and Effects of ALKS 2680 for Patients with Narcolepsy Type 1 and Type 2

Recruiting

4 1 1
Investigated diseases:
- Hypersomnia
- Narcolepsy
Investigated drugs:
- Alks 2680
Study of ENTR-601-44 in Children with Duchenne Muscular Dystrophy Who Are Eligible for Exon 44 Skipping Treatment

Recruiting

1 1 1
Investigated diseases:
- Duchenne muscular dystrophy
Investigated drugs:
- Sodium Chloride
Study of L-Annamycin and Cytarabine for Adults with Refractory or Relapsed Acute Myeloid Leukemia

Recruiting

4 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
- Annamycin
- Cytarabine
+3
Study on the Effects of Bexicaserin for Treating Seizures in Children and Adults with Dravet Syndrome

Recruiting

3 1
Investigated diseases:
- Severe myoclonic epilepsy of infancy
+5
Study of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
+6
Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

Recruiting

3 1 1 1
Investigated diseases:
- Factor VIII deficiency
Investigated drugs:
- Efanesoctocog Alfa
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies